
Patients with zzso prostate cancer who undergo zzso therapy invariably zzso and develop incurable zzso zzso zzso of the zzso zzso zzso accompanies zzso zzso We discovered that the zzso zzso zzso the expression of the tumor zzso zzso zzso zzso type II zzso but not zzso in prostate cancer zzso zzso induction of zzso by an zzso zzso required the expression of the zzso zzso zzso zzso zzso zzso zzso which leads to reduced zzso and activity of zzso In support of a key role for zzso in zzso control, zzso depletion activated zzso and increased cellular zzso The clinical significance of zzso in zzso prostate zzso was determined in normal or primary tumor prostate zzso derived from radical zzso zzso In primary tumors, the expression of both zzso and zzso was substantially reduced compared with normal zzso Further, the decreased expression of zzso reduced the time to zzso zzso Thus, zzso zzso can activate the zzso zzso via zzso zzso thereby zzso the zzso effects of zzso zzso Our findings reinforce the concept that patients undergoing zzso zzso may benefit from zzso zzso 

